Nonalcoholic Liver Disease (NAFLD) has become the most frequent hepatological entity in
the clinical practice in the developed world. The increasing number of overweight and obese …

Objectives Alcoholic liver disease (ALD) and Non-alcoholic fatty liver disease (NAFLD) are
becoming the most common causes of chronic liver diseases and the leading causes of liver …

Worldwide, obesity has nearly tripled since 1975.1 The World Health Organization (WHO)
reports that, as of 2016, more than 1.9 billion adults 18 years or older were overweight, and …

The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic
steatohepatitis (NASH) is increasing in the modern world. Fatty infiltration of the liver can be …

Nonalcoholic fatty liver disease (NAFLD) is an accumulation of extra fat in the liver cells not
caused by alcohol consumption. This disease is an increasingly common condition and the …

The prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis
(NASH) has increased rapidly worldwide, making NAFLD/NASH an important global health …

Background Hepatic steatosis is a condition frequently encountered in clinical practice, with
potential progression towards fibrosis, cirrhosis, and hepatocellular carcinoma. Detection …

Introduction: Nonalcoholic fatty liver disease (NAFLD) spans steatosis through nonalcoholic
steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). NAFLD …

Non-alcoholic fatty liver disease (NAFLD) is a chronic disease which is currently the most
common hepatic disorder affecting up to 38% of the general population with differences …

Over two-thirds of the general population of the United States is either overweight or obese.
Obesity and the metabolic syndrome are the most common risk factors for the development …